Medical equipment offering “United Kingdom Diabetes Care Devices Market Outlook to 2016” provides key market data on the United Kingdom diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
• Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the United Kingdom diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the United Kingdom diabetes care devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
Bayer HealthCare AG
LifeScan, Inc.
Sanofi-Aventis
B. Braun Melsungen AG
Abbott Laboratories
Novo Nordisk A/S
Becton, Dickinson and Company
Smiths Medical
Medtronic, Inc.
Terumo Corporation
Eli Lilly and Company
Animas Corporation
Smiths Group plc
Provalis PLC

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3188/United-Kingdom-Diabetes-Care-Devices-Market-Outlook-to-2016.html
———————————————-

Summary

New report, “The Future of the Diabetes Care Devices Market to 2016 – The Key Demand Drivers Remain Intact” provides key data, information and analysis on the global diabetes care devices market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on two diabetes care devices market categories – glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- Global Market size and company share data for three diabetes care devices market categories – glucose monitoring and insulin delivery.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
- Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
- Competitive landscape and key company profiles. Key players covered include Roche, LifeScan, Bayer, Abbott, Becton, Dickinson, Medtronic, Novo Nordisk, Sanofi-Aventis, Eli Lilly, ARKRAY, Terumo, Animas and Smiths Medical.
- Key in-pipeline products and technologies expected to hit the global diabetes care devices market in the near future.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the diabetes care devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices market and the factors shaping it.

Companies Mentioned

F. Hoffmann-La Roche Ltd
LifeScan (Johnson & Johnson)
Bayer Healthcare
Abbott Laboratories
Becton, Dickinson and Company
Medtronic
Novo Nordisk

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1207/The-Future-of-the-Diabetes-Care-Devices-Market-to-2016-The-Key-Demand-Drivers-Remain-Intact.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

The development of medical devices industry differs afar in developed countries and developing countries. In emerging markets like China and India, it is the economic growth that drives the expansion of market scale, but in most cases, the expansion just means the increase of market capacity. Comparatively, the developed countries’ market growth focuses on the new technology and the new product development. With the prevalence of digital technologies and new materials, a great change might happen to the current medical devices. As is expected, the annual sales of novel digital medical devices will hit more than US$100 billion in the following years.

America, Europe and Japan are listed top three in sequence in the global medical appliance market. The overall market size of the three occupied nearly 78% of global medical devices market in 2008. The global medical appliance market size declined 0.4 percentage points to US$206.59 billion in 2008, but a rise of 6% from a year earlier. In 2008, the China’s medical devices industry achieved CNY69.435 billion of sale, merely 5% of global market scale.

The hi-tech medical equipment, a focus of competition among multinational corporations, is also one of the fastest growing industries around the world. With the improvement of the people’s living standard, the global demand for medical healthcare has been enlarging, which stimulates the investments of countries in such field. Currently, the hi-tech medical appliance market is monopolized by only few large multinational enterprises including GE, Siemens, Toshiba, Hitachi, HP and Philips etc. Chinese market is also occupied by those multinational corps. In addition, GE announced in 2008 that it would roll out five new products to meet the demand of Chinese rural basic medical treatment market before 2010. Wuxi R&D Center (China) answers for the localized design and production of the products. The China’s local enterprises have to face strong competition from the giants in the long run.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/966/Global-and-China-Medical-Devices-Industry-Report-2009-.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com